TAILIEUCHUNG - Báo cáo khoa học: Novel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2a receptor mediated activation of MEK⁄ ERK-CREB cascade

Prostaglandin (PG) F2asuppresses adipocyte differentiation by inhibiting the function of peroxisome proliferator-activated receptor c. In this study, we identified a novel suppression mechanism, operating in the early phase of adipogenesis, that increased the production of anti-adipogenic PGF2a and PGE2by enhancing cyclooxygenase (COX) 2 | IFEBS Journal Novel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2a receptor mediated activation of MEK ERK-CREB cascade Toshiyuki Ueno and Ko Fujimori Laboratory of Biodefense and Regulation Osaka University of PharmaceuticalSciences Japan Keywords 3T3-L1 PGF2a adipocytes COX-2 CREB MEK ERK Correspondence K. Fujimori Laboratory of Biodefense and Regulation Osaka University of PharmaceuticalSciences 4-20-1 Nasahara Takatsuki Osaka 569-1094 Japan Fax 81 72 690 1215 Tel 81 72 690 1215 E-mail fujimori@ Received 6 April 2011 revised 31 May 2011 accepted 8 June 2011 doi Prostaglandin PG F2a suppresses adipocyte differentiation by inhibiting the function of peroxisome proliferator-activated receptor y. In this study we identified a novel suppression mechanism operating in the early phase of adipogenesis that increased the production of anti-adipogenic PGF2a and PGE2 by enhancing cyclooxygenase COX 2 expression through the PGF2a-activated FP receptor extracellular-signal-regulated kinase ERK cyclic AMP response element binding protein CREB cascade. COX-2 expression was enhanced with a peak at 1 h for the mRNA level and at 3 h for the protein level after the addition of Fluprostenol an FP receptor agonist. The Fluprostenol-derived elevation of COX-2 expression was suppressed by the co-treatment with an FP receptor antagonist AL8810 with a mitogen-activated protein kinase MEK ERK kinase inhibitor PD98059. ERK was phosphorylated within 10 min after the addition of Fluprostenol and its phosphorylation was inhibited by the co-treatment with AL8810 or PD98059. Moreover FP receptor mediated activation of the MEK ERK cascade and COX-2 expression increased the production of PGF2a and PGE2. An FP receptor antagonist and each inhibitor for MEK and COX-2 suppressed the PGF2a-derived induction of synthesis of these PGs. .

TỪ KHÓA LIÊN QUAN
TAILIEUCHUNG - Chia sẻ tài liệu không giới hạn
Địa chỉ : 444 Hoang Hoa Tham, Hanoi, Viet Nam
Website : tailieuchung.com
Email : tailieuchung20@gmail.com
Tailieuchung.com là thư viện tài liệu trực tuyến, nơi chia sẽ trao đổi hàng triệu tài liệu như luận văn đồ án, sách, giáo trình, đề thi.
Chúng tôi không chịu trách nhiệm liên quan đến các vấn đề bản quyền nội dung tài liệu được thành viên tự nguyện đăng tải lên, nếu phát hiện thấy tài liệu xấu hoặc tài liệu có bản quyền xin hãy email cho chúng tôi.
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.